Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2
about
Matrix-bound PAI-1 supports cell blebbing via RhoA/ROCK1 signalingInteraction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide.Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycleDiverse role of LDL receptor-related protein in the clearance of proteases and in signaling.Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance.PAI-1 inhibits neutrophil efferocytosis.Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.The status of plasminogen activator inhibitor-1 as a therapeutic target.Low density lipoprotein catabolism is enhanced by the cleaved form of alpha-1-antitrypsin.In vivo clearance of ternary complexes of vitronectin-thrombin-antithrombin is mediated by hepatic heparan sulfate proteoglycans.uPAR regulates bronchial epithelial repair in vitro and is elevated in asthmatic epithelium.Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents.
P2860
2a5fcbfdc30dea75959ee461933ec597df5b19c933856fc319f350f402289dabbf384e37fd0a27ce45dfe7dcdb6365f3afc3f32d65842cfb7bfbb80b57f32250c7c360c868d60ba24e8a081c45a034029dfba657dd2b10e28bf4a2ad4049f9d52643d949b533e8ea523c079ecabbf55ad6bad0c1c2c448abb98c931a190999a0f729cc4139473220913116ced4bc7e095372c70644327505f05cb3d43ca72237dc21a8b6d7f41ed6e25d04aee703ba103486a168e9ba89698bcafd062a70b726f355a8d7c5d3ffc6ecf5056eb1913e4d260a55aa8e6ec5300943a6ccff42e775007b09b0915c6fc9b91605338f00a30a
P248
Q27308674-22E9B62F-9D49-490A-A31E-9D3DDE058494Q29977749-C560CE7F-DD53-475E-BD94-E1990A30E4BCQ33715393-EB78727A-1370-4388-8033-7DCC1A2F269CQ35181677-522E23A2-6E5D-4543-A7BF-2D96928B6979Q35688843-5990F335-2B90-42D8-A23C-B5D7A689BFF4Q36954409-3AE7A960-045F-4E10-A456-DC175598D702Q38912052-4EB86B42-8DC6-426D-AE25-B24E6CF94406Q39793286-10E7ECD4-8569-46BD-BFD0-F07038CF10AFQ40894566-1CAC38CC-5E34-40D9-AF19-CF92462EBB4EQ41101506-C97903AA-733F-43DA-BCAF-6D503ECCBF9BQ41925724-F1F432B5-4DB8-4C5F-BEA2-18FCB5F49419Q42176625-0659B148-587C-4E82-ADA7-A490C5E9C9CFQ46817750-DAC049EB-64EE-4912-86A6-C12B911BA94A
P2860
Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@ast
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@en
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@en-gb
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@nl
type
label
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@ast
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@en
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@en-gb
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@nl
prefLabel
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@ast
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@en
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@en-gb
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@nl
P2093
P2860
P921
P356
P1476
Plasminogen activator inhibito ...... eptor-related proteins 1 and 2
@en
P2093
D A Lawrence
S Stefansson
W S Argraves
P2860
P304
P356
10.1074/JBC.271.14.8215
P407
P577
1996-04-05T00:00:00Z